Evidence map›Paper›PMID 30944706›Full record

ArticleIranian journal of basic medical sciences2019

Molecular epidemiology of colistin-resistant

Ahmad Farajzadeh Sheikh, Mojtaba Shahin, Leili Shokoohizadeh, Mehrdad Halaji, Fereshteh Shahcheraghi, Fahimeh Ghanbari

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of basic medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Prevalence and Molecular Typing of Colistin-ResistantInfection and drug resistance · 2020
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Ahmad Farajzadeh SheikhDepartment of Microbiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Mojtaba ShahinDepartment of Microbiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Leili ShokoohizadehDepartment of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Mehrdad HalajiDepartment of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Fereshteh ShahcheraghiDepartment of Bacteriology, Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Fahimeh GhanbariStudent Research Committee, School of Medicine, Shahid Saddoughi University of Medical Sciences, Yazd, Iran.
Ahvaz Jundishapur University of Medical Sciences · IRHamedan University of Medical Sciences · IRIsfahan University of Medical Sciences · IRPasteur Institute of Iran · IRShahid Sadoughi University of Medical Sciences and Health Services · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesResistance to carbapenems is the principal reason for the continuing utilization of colistin as a last resort choice for treating the infections resulted from multidrug carbapenem-resistant MATERIALS AND

methodsThe current cross-sectional research was conducted on 269 CRPA isolates collected from various clinical samples from 2013 to 2016. After performing identification tests, disk diffusion as well as MIC methods were used for testing sensitivity to the antibiotics. Modified Hodge Test (MHT) was utilized to produce carbapenemase. PCR technique identified beta-lactamase classes A, B, and D genes.

resultsIn total, from 269 CRPA, five isolates (1.3%) were resistant to colistin. It was found that

conclusionThe appearance of colistin-resistant isolates in CRPA carrying

Indexed as

bla NDM-1ColistinDouble-locus sequence typingDrug resistancePseudomonas aeruginosa

Identifiers

PMID30944706
PMCPMC6437460
OpenAlexW2899326521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.